The Miracle Baby Grows Up: Hypoplastic Left Heart Syndrome in the Adult

Matthew Lewis1, Marlon Rosenbaum2

  • 1Herbert Irving Pavilion, 161 Fort Washington Ave Suite 627, New York, NY, 10032, USA. ml3329@cumc.columbia.edu.

Insights

Hypoplastic left heart syndrome (HLHS) patients now survive to adulthood but face lifelong complications from single-ventricle palliation. Recognizing and addressing these challenges is crucial for improving long-term outcomes and quality of life.

Area of Science:

  • Adult congenital heart disease
  • Single-ventricle palliation
  • Hypoplastic left heart syndrome (HLHS)

Background:

  • Hypoplastic left heart syndrome (HLHS) is a complex congenital heart defect characterized by underdevelopment of the left heart.
  • Historically fatal in infancy, modern surgical techniques now enable HLHS patients to reach adulthood.
  • Despite improved survival, significant long-term morbidity and mortality persist in the adult HLHS population.

Purpose of the Study:

  • To review common sources of morbidity and mortality in adult patients with Hypoplastic left heart syndrome (HLHS).
  • To identify areas requiring further research to improve the prognosis and quality of life for this growing patient group.
  • To emphasize the importance of understanding lifelong challenges associated with single-ventricle repair.

Main Methods:

  • This review synthesizes current literature on the long-term outcomes of Hypoplastic left heart syndrome (HLHS).
  • Analysis focuses on complications arising from single-ventricle palliation, particularly the Fontan procedure.
  • Identifies patient-specific risks and areas for future clinical investigation.

Main Results:

  • Adults with palliated Hypoplastic left heart syndrome (HLHS) experience significant lifelong morbidity due to elevated systemic venous pressures post-Fontan procedure.
  • Downstream organ dysfunction is a major concern, influencing management and organ allocation decisions.
  • Patients with a morphologic systemic right ventricle, common in HLHS, may face even higher risks.

Conclusions:

  • The growing adult Hypoplastic left heart syndrome (HLHS) population requires increased recognition of their unique lifelong health challenges.
  • A collaborative approach between patients and healthcare providers is essential to address clinical uncertainties.
  • Continued research and coordinated care are vital for enhancing patient prognosis and quality of life.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
693
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
851
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
930
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K